Treace Medical Concepts, Inc.
$1.97
▲
2.84%
2026-04-21 09:50:01
www.treace.com
NMS: TMCI
Explore Treace Medical Concepts, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$125.31 M
Current Price
$1.97
52W High / Low
$7.78 / $1.17
Stock P/E
—
Book Value
$1.37
Dividend Yield
—
ROCE
-33.86%
ROE
-58.94%
Face Value
—
EPS
$-0.93
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
450
Beta
0.88
Debt / Equity
82.29
Current Ratio
4.31
Quick Ratio
3.13
Forward P/E
-2.01
Price / Sales
0.55
Enterprise Value
$140.1 M
EV / EBITDA
-3.15
EV / Revenue
0.66
Rating
Hold
Target Price
$4.25
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Lumexa Imaging Holdings, Inc. | $9.65 | — | $928.42 M | — | 1.69% | -12.6% | $19.45 / $7.23 | $6.1 |
| 2. | Tenon Medical, Inc. | $0.8 | — | $9.06 M | — | -169.5% | -2.28% | $2.48 / $0.64 | $0.18 |
| 3. | Avanos Medical, Inc. | $24.64 | — | $1.15 B | — | 1.7% | -9.07% | $24.72 / $9.3 | $16.75 |
| 4. | QuidelOrtho Corporation | $12.89 | — | $877.57 M | — | 1.14% | -46.15% | $38.99 / $11.61 | $28.28 |
| 5. | AVITA Medical, Inc. | $5 | — | $157.45 M | — | 676.75% | 799.72% | $10.29 / $3.22 | $-0.55 |
| 6. | Masimo Corporation | $178.4 | 46.03 | $9.34 B | — | 23.57% | 23.43% | $179 / $125.94 | $13.84 |
| 7. | Zimmer Biomet Holdings, Inc. | $94.32 | 26.61 | $18.29 B | 1.04% | 6.61% | 5.6% | $108.29 / $84.59 | $64.95 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 62.52 M | 50.21 M | 47.39 M | 52.57 M | 68.71 M | — |
| Operating Profit | -5.92 M | -15.68 M | -16.97 M | -15.58 M | -0.2 M | — |
| Net Profit | -9.39 M | -16.29 M | -17.4 M | -15.92 M | -0.5 M | — |
| EPS in Rs | -0.15 | -0.25 | -0.27 | -0.25 | -0.01 | -0.25 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 212.69 M | 209.36 M | 187.12 M | 141.84 M |
| Operating Profit | -54.15 M | -55.69 M | -51.43 M | -34.84 M |
| Net Profit | -59 M | -55.74 M | -49.53 M | -42.81 M |
| EPS in Rs | -0.91 | -0.86 | -0.76 | -0.66 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 190.58 M | 217.09 M | 251.91 M | 159.02 M |
| Total Liabilities | 103.25 M | 104.2 M | 113.97 M | 98.5 M |
| Equity | 87.33 M | 112.89 M | 137.94 M | 60.53 M |
| Current Assets | 132.05 M | 161.4 M | 198.36 M | 133.4 M |
| Current Liabilities | 30.64 M | 34.92 M | 45.03 M | 30.25 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -15.97 M | -37.17 M | -34.58 M | -30.65 M |
| Investing CF | 13.25 M | 35.38 M | -81.3 M | -76.52 M |
| Financing CF | 2.08 M | 0.16 M | 109.38 M | 20.81 M |
| Free CF | -29.49 M | -48.76 M | -46.03 M | -45.49 M |
| Capex | -13.52 M | -11.59 M | -11.46 M | -14.84 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 11.89% | 31.92% | — | — |
| Earnings Growth % | -12.55% | -15.68% | — | — |
| Profit Margin % | -26.63% | -26.47% | -30.19% | — |
| Operating Margin % | -26.6% | -27.48% | -24.57% | — |
| Gross Margin % | 80.37% | 81.2% | 82% | — |
| EBITDA Margin % | -20.09% | -20.85% | -25.58% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.